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ABSTRACT. Bacteria collected in mosquito breeding ponds were evaluated for resistance to strepto-
mycin, chloramphenicol, penicillin and trimethoprim. Mycelial growth of Lagenidium giganteum isolates
from Australia, United States and Colombia were evaluated in PYG media containing one antibiotic or
a mixture of these compounds. Media containing chloramphenicol reduced mycelial growth of most of
the isolates. The antibiotic mixtures and penicillin-streptomycin penicillin-trimethoprim did not signif-
icantly affect mycelial growth of the isolates; however, the iater substantialiy reduced bacterial contam-
ination.
Lagenidium giganteunl Couch, a water mold
of the Class Oomycetes, is a facultative parasite
of mosquito larvae. Kerwin et al. (1990) con-
cluded that this pathogenic fungus could be used
safely for mosquito control operations. On dif-
ferent occasions between 1985 and 1987, Frances
et al. (1989), isolated L. giganteum in Millaa
Millaa, Australia. Recently, we have isolated
and examined the pathogenicity to mosquito
larvae of 5 new isolates of L. giganteum from 3
different areas in Colombia (Orduz, unpublished
data). In all cases, the isolation methodology
described by Brey and Remaudiere (1985) was
followed; however, the normal bacterial inhab-
itants of these ponds were resistant to penicillin
and in many cases to streptomycin, thus com-
plicating the isolation procedures.
In the present study, a comparison of the
effect of some antibiotics on the mycelial growth
of L. giganteum isolates from Australia, United
States and Colombia is presented, and a new
antibiotic mixture for the isolation of L. gigan-
teurn from the Colombian tropics is given.
Lagenidium giganteurn California (CA) was
obtained from P. T. Brey, Institut Pasteur,
Paris; North Carolina (NC), and Louisiana (LA)
isolates were obtained from J. Kerwin, Univer-
sity of Washington, Seattle, Washington; the
Australian isolate (ARSEF 2532) was obtained
from A. W. Sweeney, Army Malaria Research
Unit, New South Wales. These isolates and the
Colombian (CIB) strains used in these experi-
ments were maintained on sunflower seed ex-
tract (SFE) agar as described by Guzman and
Axtell (1986) at room temperature (23 + 3'C),
and subcultured from dead larvae every 2-3
weeks.
Aquatic bacteria collected from 15 mosquito
larval habitats belonged to 17 species and 7
genera. All bacterial species tested according to
standard procedures (NCCLS 1984) were resist-
ant to 10 units of penicillin; one species was
resistant to 30 pg of chloramphenicol; 4 species
were resistant to 50 pg of streptomycin; and
5 species were resistant to 1.25/23.75 pg of
trimethoprim/sulphamethoxazole respectively(data not shown).
Lagenidium giganteurn mycelial growth was
measured 36 h after transferring 20 mm'  SFE-
agar discs containing mycelia of each isolate of
L. giganteum to PYG (per liter, peptone 1.3 g,
yeast extract 1.3 g and glucose 3 g) with antibi-
otics to a final concentration of 0.05% of each
antibiotic or mixture of them, penicillin V 10,000
units (PYGP), streptomycin 10 mglml (PYGS),
chloramphenicol 6 mg/ml (PYGC) and trimeth-
oprim-3 mg/ml (PYGPT), and mixtures of pen-
icillin-streptomycin (PYGPS), penicillin-chlor-
amphenicol (PYGPC), penicillin-trimethoprim
(PYGPT), and penicillin-streptomycin-chlor-
amphenicol (PYGPSC). Ninety-six hours after
fungal isolates were transferred to PYG with
antibiotics,4 mm diameter discs containing fun-
gal mycelia were transferred to PYG without
antibiotics, and measurements of radial growth
were taken after 36 h. Data were analyzed by
analysis of variance and means compared using
Tukey's test (Systat, Statistics/Tukey).
At the concentrations tested, penicillin and
streptomycin had no adverse effects on mycelial
growth on any of the ,L. giganteum isolates.
Radial growth ranged between 12.2 mm in iso-
late CIB 164-PDCH to 0.6 mm in CIB 79-MED.
Growth of most of the isolates in PYGPS was
not affected by these antibiotics; however, for
isolates CIB 183-ARU and CIB 183-NUQ,
growth was significantly reduced. Isolates grow-
ing in PYGPT were not significantly different
from their respective controls except for isolate
CIB 183-NUQ. In all isolates tested, growth in
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PYGC, PYGPC, and PYGPSC was reduced
compared with their controls except for isolates
CIB 79-MED and 79-TDT growing in PYGC
and isolate CIB 79-MED growing in PYGPC
and PYGPSC. Isolate CIB 183-NUQ was the
most susceptible to antibiotic treatments (Table
1 ) .
When agar discs from each isolate, antibiotic
treatment and controls were transferred to
PYG-agar without antibiotics, definite growth
trends were observed. After 36 h of transfer,
growth of the isolates CA, ARSEF 2b32, CIB
79-MED and 183-ARU did not differ from their
controls. Length of mycelia in isolates CIB 164-
PDCH, LA, NC, CIB 79-TDT and CIB 183-
NUQ coming from treatments with chloram-
phenicol was significantly reduced. However,
isolate CIB 183-NUQ, which was severely af-
fected by treatments PYGC and PYGPSC, com-
pletely recovered and did not show any signifi-
cant difference from its control (Table 1).
The lower rate of mycelial growth observed in
some treatments after transferring the mycelia
to the media without antibiotics could be due to
the effect of antibiotic residues on the trans-
ferred mycelia. Antifungal activity has been
demonstrated for some d-lactam compounds(Gottstein et al. 1971), for antibiotics acting by
blocking protein synthesis (Roberts 1980), and
for those which act by inhibiting folic acid syn-
thesis (Lopes and Armond 1968).
The reduced bacterial contamination in the
isolation medium PYGPT readily permitted the
isolation of fungal mycelia. This isolation pro-
cedure was easier due to faster mycelial growth
in all antibiotic treatments (range of radius 2.9-
72 mm/36 h), with the exception of isolate CIB
79-MED (0.6 mm/36 h) compared with the one
obtained from Brey and Remaudiere (1985), 10
mm/7 days, and in some cases to the isolation
methodology described by Frances et al. (1989)(diam 25-30 mm/ll days), who used the anti-
biotics described by Rueda and Axtell (1991).
Differences in mycelial growth pattern found by
the Brey and Remaudiere study (1985) and
Frances et al. (1989) could be due to the reduced
space furnished by the test tubes used to isolate
the fungus relative to the petri dishes used in
these experiments. The petri dishes supply the
fungi with more nutrients and space to grow,
facilitating the isolation procedure.
Reduced bacterial contaminants and the high-
est growth rate showed by L. giganteum isolates
in the treatment PYGPT, recommend it as a
good medium for isolation of this fungus in
Colombia and other parts of the world.
Table 1. Effbct o1 4 antibiotics, their mixtures and residual effect on the mycelial growth rate of Lagenidium
giganteum strains from Australia (ARSEF), United States (NC, CA, LA) and Colombia (CIB).
Radius of mycelial growth oi l. giganteum isolates after 48 h*
Treatment NC LACA
ARSEF CIB 163- CIB 79-
2532 PDCH TDT
CIB 79- CIB 183- CIB 183-
MED ARU NUQ
PYG 3.5a 3. la
PYGP 3.2a 3.0a
PYGS 3.0a 3.0a
PYGC I.2a 0.8b
PYGPS 3.1a 7. la
PYGPC 0.3b 0.7b
PYGPT 2.7a 2.7a
PYGPSC O.4b O.5b
PYG 4.2a 2.9a
PYGP 4.5a 3.0a
PYGS 4.9a 3.0a
PYGC 3.2b 2.7a
PYGPS 4.0a 1.5a
PYGPC 3.2b 3.0a
PYGPT 5.0a 3.0a
PYGPSC 3.0b 3.0a
With antibiotics
3.0a 12.2a
2.7 a 11.0a
2.7a 12.2a
1.0a 4.2b
3.0a ll.7a
0.9b 3.2bc
2.9a 12.0a
0.5b 2.5c
After antibiotics
4 .5a  11 .5a
4.7a  11 .5a
4.0a 9.0b
1.0b 9.0b
4.7a 10.0ab
4.5a 7.2bc
4.Oa 10.0a
4.2a 7.0c
6.2a 5.2a
5.5ab 4.0ab
6.2a 4.5ab
1.5d 0.7c
4.5b 3.2b
l.7cd 0.9c
6.0a 3.5b
2.9c 0.9c
4.0a 2.7a
4.0a 2.7a
4.0a 2.2b
3.2a 4.5a
4.0a 2.5b
4.0a 2.0b
3.7a 1.7b
4.0a 3.5a
4.Oa
3.7a
3.7a
0.6b
3.9a
1.0b
4.0a
1.3b
4.5a
4.5a
2 .5h
3.5a
4.0a
4.3a
3.8a
4. la
4.0a
4 . l a
0.7b
4.0a
0.4b
4.0a
0.6b
3.5a
3.2a
3.7a
4.2a
3.7a
3.0a
3.2a
3.5a
0.7a
0.6a
0.7a
0.6a
0.5a
0.1a
0.6a
0.1a
2.2a
0.9a
1.5a
l . z a
1 .5a
2.2a
1 .5a
r .  t a
* Measurements in millimeters. Mean values are the result of 2 tests with 4 replicates per treatment. Means
lbllowed by the same letter in each category (with antibiotics and after antibiotics) in each coiumn are not
significantly diflerent (Tukey HSD, alpha : 0.05). CIB, Corporaci6n para Investigaciones Biologicas.
PYG: Peptone, yeast extract, glucose; C; Cloramphenicol, P: Penicillin, S: Streptomycin, T: Trimethoprim.
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